{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:59:00Z","timestamp":1790985540708,"version":"4.1.0"},"reference-count":273,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"crossref","award":["503\/1-156-04\/503-11-001"],"award-info":[{"award-number":["503\/1-156-04\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"crossref"}]},{"award":["503\/1-156-04\/503-11-001"],"award-info":[{"award-number":["503\/1-156-04\/503-11-001"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Triple-negative breast cancer (TNBC) is one of the most aggressive and clinically challenging subtypes of breast cancer, defined by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. The lack of actionable molecular targets contributes to limited therapeutic options, frequent recurrence, and a high propensity for distant metastasis. Metastatic dissemination remains the principal cause of mortality in patients with TNBC and is driven by complex molecular mechanisms involving multiple interconnected signaling networks. This review summarizes current knowledge of the molecular mechanisms underlying metastatic progression in TNBC, with particular emphasis on signaling pathways that regulate tumor invasion, migration, and colonization of distant organs. We discuss the roles of key pathways, including PI3K\/Akt, TGF-\u03b2, Wnt\/\u03b2-catenin, NF-\u03baB, and Rho\/ROCK signaling, in the regulation of epithelial\u2013mesenchymal transition, cytoskeletal remodeling, cancer stem cell phenotypes, and tumor\u2013microenvironment interactions. A deeper understanding of these signaling networks may facilitate the identification of novel therapeutic targets and support the development of more effective strategies to limit metastatic disease in TNBC.<\/jats:p>","DOI":"10.3390\/cells15090809","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:32:22Z","timestamp":1777469542000},"page":"809","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Signaling Networks Regulating Metastatic Progression in Triple-Negative Breast Cancer"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1243-721X","authenticated-orcid":false,"given":"Zuzanna","family":"Senkowska","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-2406","authenticated-orcid":false,"given":"Katarzyna","family":"Owczarek","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-3243","authenticated-orcid":false,"given":"Karolina","family":"Niewinna","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5995-6168","authenticated-orcid":false,"given":"Urszula","family":"Lewandowska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, 92-215 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tjog.2023.11.012","article-title":"Favorable breast cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures","volume":"63","author":"Chou","year":"2024","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-021-03190-7","article-title":"Male breast cancer: An update","volume":"480","author":"Fox","year":"2022","journal-title":"Virchows Arch."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11912-023-01489-z","article-title":"Male breast cancer: A review on diagnosis, treatment, and survivorship","volume":"26","author":"Bhardwaj","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Freihat, O., Sipos, D., and Kovacs, A. (2025). Global burden and projections of breast cancer incidence and mortality to 2050: A comprehensive analysis of GLOBOCAN data. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1622954"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20211033","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnolda","year":"2022","journal-title":"Breast"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41698-018-0047-0","article-title":"Organotropism: New insights into molecular mechanisms of breast cancer metastasis","volume":"2","author":"Chen","year":"2018","journal-title":"npj Precis. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26717","DOI":"10.1038\/s41598-025-12883-x","article-title":"Patterns and prognostic implications of distant metastasis in breast cancer based on SEER population data","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"16","author":"Steeg","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: Past, present, and future","volume":"286\u2013287","author":"Sonkin","year":"2024","journal-title":"Cancer Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"92982","DOI":"10.5662\/wjm.v14.i2.92982","article-title":"Revisiting the standards of cancer detection and therapy alongside their comparison to modern methods","volume":"14","author":"Gromek","year":"2024","journal-title":"World J. Methodol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"De Sanctis, R., Tiberio, P., Zambelli, A., and Santoro, A. (2024). Transforming Breast Cancer Care: Cutting-Edge Insights and Future Directions. J. Clin. Med., 13.","DOI":"10.3390\/jcm13226697"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"121.","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dynarowicz, K., Bartusik-Aebisher, D., Czech, S., Kawczyk-Krupka, A., and Aebisher, D. (2026). A Decade of Innovation in Breast Cancer (2015\u20132025): A Comprehensive Review of Clinical Trials, Targeted Therapies and Molecular Perspectives. Cancers, 18.","DOI":"10.3390\/cancers18030361"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: Pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","article-title":"Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4736091","DOI":"10.1155\/2020\/4736091","article-title":"Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics","volume":"2020","author":"Tuasha","year":"2020","journal-title":"Scientifica"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"117009","DOI":"10.1016\/j.lfs.2019.117009","article-title":"Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations","volume":"239","year":"2019","journal-title":"Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","article-title":"Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression","volume":"125","author":"Tiede","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00363-1","article-title":"Breast cancer heterogeneity and its implication in personalized precision therapy","volume":"12","author":"Guo","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_22","first-page":"e1779","article-title":"Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes","volume":"6","author":"Zajac","year":"2023","journal-title":"Cancer Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.21873\/anticanres.17643","article-title":"Unlocking new frontiers in breast cancer: The role of the tumor microenvironment, cutting-edge therapies, and immunotherapy","volume":"45","author":"Kamyan","year":"2025","journal-title":"Anticancer. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"210120","DOI":"10.1098\/rsob.210120","article-title":"The intrinsically disorderly story of Ki-67","volume":"11","author":"Remnant","year":"2021","journal-title":"Open Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: From the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Davey, M.G., Hynes, S.O., Kerin, M.J., Miller, N., and Lowery, A.J. (2021). Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers, 13.","DOI":"10.3390\/cancers13174455"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","article-title":"Ki-67 gene expression","volume":"28","author":"Uxa","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29289\/25945394202020200024","article-title":"Histological and molecular classification of breast cancer: What do we know?","volume":"30","author":"Nascimento","year":"2020","journal-title":"Mastology"},{"key":"ref_29","first-page":"245","article-title":"The utility of the 21-gene Oncotype DX Breast Recurrence Score\u00ae assay in node-negative breast cancer patients\u2014The final analysis of the Polish real-life survey PONDx","volume":"28","author":"Litwiniuk","year":"2024","journal-title":"Contemp. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wallden, B., Storhoff, J., Nielsen, T., Dowidar, N., Schaper, C., Ferree, S., Liu, S., Leung, S., Geiss, G., and Snider, J. (2015). Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med. Genom., 8.","DOI":"10.1186\/s12920-015-0129-6"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/gcc.23014","article-title":"MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients","volume":"61","author":"Haan","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-022-06698-x","article-title":"BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance","volume":"195","author":"Kuilman","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40291-021-00525-7","article-title":"Luminal breast cancer: Risk of recurrence and tumor-associated immune suppression","volume":"25","author":"Pellegrino","year":"2021","journal-title":"Mol. Diagn. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41523-023-00589-0","article-title":"Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer","volume":"9","author":"Veerla","year":"2023","journal-title":"npj Breast Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Carvalho, E., Canberk, S., Schmitt, F., and Vale, N. (2025). Molecular subtypes and mechanisms of breast cancer: Precision medicine approaches for targeted therapies. Cancers, 17.","DOI":"10.3390\/cancers17071102"},{"key":"ref_37","first-page":"101","article-title":"Prognostic significance and molecular classification of triple negative breast cancer: A systematic review","volume":"21","author":"Dogra","year":"2025","journal-title":"Eur. J. Breast Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cpet.2015.05.007","article-title":"PET\/Computed tomography using new radiopharmaceuticals in targeted therapy","volume":"10","author":"Sharma","year":"2015","journal-title":"PET Clin."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chen, P., Li, B., and Ou-Yang, L. (2022). Role of estrogen receptors in health and disease. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.839005"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.jmb.2016.06.020","article-title":"Progesterone receptor signaling mechanisms","volume":"428","author":"Grimm","year":"2016","journal-title":"J. Mol. Biol."},{"key":"ref_41","first-page":"5214","article-title":"New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling","volume":"11","author":"Azeez","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104154","DOI":"10.1016\/j.esmoop.2025.104154","article-title":"The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: An analysis of the data trial","volume":"10","author":"Lammers","year":"2025","journal-title":"ESMO Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1021\/acs.jmedchem.4c01591","article-title":"A novel HER2 protein identification methodology in breast cancer cells using Raman Spectroscopy and Raman Imaging: An Analytical Validation Study","volume":"67","author":"Abramczyk","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41523-021-00265-1","article-title":"HER2-positive breast cancer and tyrosine kinase inhibitors: The time is now","volume":"7","author":"Schlam","year":"2021","journal-title":"npj Breast Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"188448","DOI":"10.1016\/j.bbcan.2020.188448","article-title":"New insights into affinity proteins for HER2-targeted therapy: Beyond trastuzumab","volume":"1874","author":"Akbari","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e34772","DOI":"10.1097\/MD.0000000000034772","article-title":"Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer","volume":"102","author":"Kang","year":"2023","journal-title":"Medicine"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Akay, S., Emiroglu, M., Kelten Talu, C., and Unal, O.U. (2025). Comparison of Clinicopathological Characteristics for HER2-Null, HER2-Ultralow and HER2-Low Breast Cancer: A Single-Center Study. Medicina, 61.","DOI":"10.2139\/ssrn.5037867"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/BCTT.S366122","article-title":"HER2-Low Breast Cancer: Current Landscape and Future Prospects","volume":"15","author":"Shirman","year":"2023","journal-title":"Breast Cancer Targets Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12282-024-01617-y","article-title":"Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine","volume":"31","author":"Kitadai","year":"2024","journal-title":"Breast Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lehmann, B.D., Jovanovi\u0107, B., Chen, X., Estrada, M.V., Johnson, K.N., Shyr, Y., Moses, H.L., Sanders, M.E., and Pietenpol, J.A. (2016). Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157368"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/j.clbc.2018.07.023","article-title":"Genetic Markers in Triple-Negative Breast Cancer","volume":"18","author":"Sporikova","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41523-020-00197-2","article-title":"Practical classification of triple-negative breast cancer: Intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies","volume":"6","author":"Marra","year":"2020","journal-title":"npj Breast Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","article-title":"Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies","volume":"35","author":"Jiang","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s40610-015-0027-x","article-title":"Context-Dependent Function of Myoepithelial Cells in Breast Morphogenesis and Neoplasia","volume":"1","author":"Ingthorsson","year":"2015","journal-title":"Curr. Mol. Biol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/annonc\/mdy024","article-title":"Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis","volume":"29","author":"Bareche","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1038\/oncsis.2017.14","article-title":"Wnt signaling in triple-negative breast cancer","volume":"6","author":"Pohl","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.breast.2013.08.007","article-title":"Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?","volume":"22","author":"Chiorean","year":"2013","journal-title":"Breast"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s12672-025-03431-0","article-title":"Advances of androgen receptor in triple-negative breast cancer: From molecular mechanisms to clinical applications","volume":"16","author":"Ma","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Humphries, B., Wang, Z., and Yang, C. (2020). Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses. Cells, 9.","DOI":"10.3390\/cells9102167"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"168","DOI":"10.18632\/oncotarget.28701","article-title":"Signaling pathway dysregulation in breast cancer","volume":"16","author":"Ryspayeva","year":"2025","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr3605","article-title":"PIK3CA mutations in breast cancer: Reconciling findings from preclinical and clinical data","volume":"16","author":"Zardavas","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt signaling in breast cancer: Biological mechanisms, challenges and opportunities","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI65416","article-title":"TGF-\u03b2 inhibition enhances chemotherapy action against triple-negative breast cancer","volume":"123","author":"Bhola","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1530\/VB-21-0008","article-title":"Rho GTPase signalling networks in cancer cell transendothelial migration","volume":"3","author":"Rodenburg","year":"2021","journal-title":"Vasc. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Sheppard","year":"2023","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-022-02476-1","article-title":"Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications","volume":"41","author":"Asleh","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41419-025-07873-w","article-title":"Molecular features of TNBC govern heterogeneity in the response to radiation and autophagy inhibition","volume":"16","author":"Fischer","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, L., Wu, N., Zhuang, G., Geng, L., Zeng, Y., Wang, X., Wang, S., Ruan, X., Zheng, X., and Gao, M. (2023). Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1224828"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: A hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-019-0092-3","article-title":"Engineered models to parse apart the metastatic cascade","volume":"3","author":"Hapach","year":"2019","journal-title":"npj Precis. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","article-title":"Initial steps of metastasis: Cell invasion and endothelial transmigration","volume":"728","author":"Krupitza","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"100899","DOI":"10.1016\/j.tranon.2020.100899","article-title":"Plasticity of cancer cell invasion: Patterns and mechanisms","volume":"14","author":"Wu","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jb\/mvaa003","article-title":"Tactics of cancer invasion: Solitary and collective invasion","volume":"167","author":"Nagai","year":"2020","journal-title":"J. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"101872","DOI":"10.1016\/j.xcrm.2024.101872","article-title":"The metastatic cascade through the lens of therapeutic inhibition","volume":"6","author":"Miranda","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1111\/febs.16046","article-title":"The gate to metastasis: Key players in cancer cell intravasation","volume":"289","author":"Sznurkowska","year":"2022","journal-title":"FEBS J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"H29","DOI":"10.1530\/VB-20-0007","article-title":"Endothelial cells on the move: Dynamics in vascular morphogenesis and disease","volume":"2","author":"Fonseca","year":"2020","journal-title":"Vasc. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Basak, U., Sarkar, T., Mukherjee, S., Chakraborty, S., Dutta, A., Dutta, S., Nayak, D., Kaushik, S., Das, T., and Sa, G. (2023). Tumor-associated macrophages: An effective player of the tumor microenvironment. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1295257"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-319-42023-3_5","article-title":"Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment","volume":"936","author":"Rejniak","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and metastasis in cancer: Molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: Biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s43556-020-00022-z","article-title":"Characteristics of pre-metastatic niche: The landscape of molecular and cellular pathways","volume":"2","author":"Wang","year":"2021","journal-title":"Mol. Biomed."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: Formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/PAP.0000000000000219","article-title":"Paget\u2019s \u201cSeed and Soil\u201d Theory of Cancer Metastasis: An Idea Whose Time has Come","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv. Anat. Pathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13578-023-01171-8","article-title":"Predictive and prognostic biomarkers of bone metastasis in breast cancer: Current status and future directions","volume":"13","author":"Wang","year":"2023","journal-title":"Cell Biosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/OP.23.00794","article-title":"Breast Cancer Brain Metastasis: A Comprehensive Review","volume":"20","author":"Raghavendra","year":"2024","journal-title":"JCO Oncol. Pract."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Liu, C., Mohan, S.C., Wei, J., Seki, E., Liu, M., Basho, R., Giuliano, A.E., Zhao, Y., and Cui, X. (2022). Breast cancer liver metastasis: Pathogenesis and clinical implications. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1043771"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Xie, Y., Lei, C., Ma, Y., Li, Y., Yang, M., Zhang, Y., Law, K.N., Wang, N., and Qu, S. (2024). Prognostic nomograms for breast cancer with lung metastasis: A SEER-based population study. BMC Women\u2019s Health, 24.","DOI":"10.1186\/s12905-023-02848-5"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Min, Y., Liu, X., Hu, D., Chen, H., Chen, J., Xiang, K., Yin, G., Han, Y., Feng, Y., and Luo, H. (2021). Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node Metastasis. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.771226"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1309\/AJCPYO5FSV3UPEXS","article-title":"Breast cancer subtypes predispose the site of distant metastases","volume":"143","author":"Soni","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: A SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kesireddy, M., Elsayed, L., Shostrom, V.K., Agarwal, P., Asif, S., Yellala, A., and Krishnamurthy, J. (2024). Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis. Cancers, 16.","DOI":"10.20944\/preprints202404.1138.v1"},{"key":"ref_94","first-page":"1750834","article-title":"Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Lin, S., Mo, H., Li, Y., Guan, X., Chen, Y., Wang, Z., and Xu, B. (2021). Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-09038-2"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/cam4.1370","article-title":"Risk factors and survival outcomes in patients with breast cancer and lung metastasis: A population-based study","volume":"7","author":"Xiao","year":"2018","journal-title":"Cancer Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cheng, Z., Erhardt, S., and Wang, J. (2025). Rho\/ROCK Pathway as a Therapeutic Target in Multiple Diseases. Int. J. Drug Discov. Pharmacol., 4.","DOI":"10.53941\/ijddp.2025.100018"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Rascio, F., Spadaccino, F., Rocchetti, M.T., Castellano, G., Stallone, G., Netti, G.S., and Ranieri, E. (2021). The Pathogenic Role of PI3K\/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers, 13.","DOI":"10.3390\/cancers13163949"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/OTT.S493643","article-title":"Exploring TGF-\u03b2 Signaling in Cancer Progression: Prospects and Therapeutic Strategies","volume":"18","author":"Sheikh","year":"2025","journal-title":"OncoTargets Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","article-title":"Wnt signaling pathways in biology and disease: Mechanisms and therapeutic advances","volume":"10","author":"Xue","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cm.20472","article-title":"Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell polarity","volume":"67","author":"Amano","year":"2010","journal-title":"Cytoskeleton"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1158\/0008-5472.CAN-16-3141","article-title":"ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA","volume":"77","author":"Humphries","year":"2017","journal-title":"Cancer Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Clayton, N.S., and Ridley, A.J. (2020). Targeting Rho GTPase Signaling Networks in Cancer. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00222"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","article-title":"Novel Insights into the Roles of Rho Kinase in Cancer","volume":"64","author":"Wei","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/mol.115.097857","article-title":"G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation","volume":"88","author":"Yu","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cm.21894","article-title":"Enhanced RHO-ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma","volume":"81","author":"Pittar","year":"2024","journal-title":"Cytoskeleton"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.18632\/oncotarget.9395","article-title":"Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context","volume":"7","author":"Matsubara","year":"2016","journal-title":"Oncotarget"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1038\/s41598-017-14216-z","article-title":"ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells","volume":"7","author":"Guerra","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yexcr.2017.09.020","article-title":"Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells","volume":"360","author":"Cascione","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Kontomaris, S.V., Malamou, A., and Stylianou, A. (2025). The Young\u2019s Modulus as a Mechanical Biomarker in AFM Experiments: A Tool for Cancer Diagnosis and Treatment Monitoring. Sensors, 25.","DOI":"10.3390\/s25113510"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.7150\/jca.45897","article-title":"Comparison of Cancer Cell Elasticity by Cell Type","volume":"11","author":"Kwon","year":"2020","journal-title":"J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"16351","DOI":"10.1038\/s41598-019-52746-w","article-title":"Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling","volume":"9","author":"Kalpana","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"17455","DOI":"10.1038\/s41598-021-96709-6","article-title":"The RhoA dependent anti-metastatic function of RKIP in breast cancer","volume":"11","author":"Kalpana","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"73593","DOI":"10.18632\/oncotarget.12435","article-title":"NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA\/ROCK pathway signal transduction","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"37","DOI":"10.58567\/ci03020001","article-title":"LTBP1 promotes the progression of triple negative breast cancer via activating the RhoA\/ROCK signaling pathway","volume":"3","author":"Zhang","year":"2023","journal-title":"Cancer Insight"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e70013","DOI":"10.1002\/biof.70013","article-title":"The role of NRF2 transcription factor in inflammatory skin diseases","volume":"51","author":"Salman","year":"2025","journal-title":"Biofactors"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e70295","DOI":"10.1002\/mco2.70295","article-title":"PI3K\/AKT\/mTOR Axis in Cancer: From Pathogenesis to Treatment","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.3892\/mmr.2017.6415","article-title":"Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer","volume":"15","author":"Bredemeier","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: An important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10549-012-2389-6","article-title":"PI3K\/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: Implications for targeted therapy","volume":"138","author":"Wander","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Song, X., Wei, C., and Li, X. (2022). The Signaling Pathways Associated With Breast Cancer Bone Metastasis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.855609"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2018.11.038","article-title":"Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis","volume":"443","author":"Yuan","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-19-0180","article-title":"mTORC2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis","volume":"79","author":"Zhang","year":"2019","journal-title":"Cancer Res."},{"key":"ref_127","first-page":"443","article-title":"Nrf3 promotes the proliferation and migration of triple-negative breast cancer by activating PI3K\/AKT\/mTOR and epithelial-mesenchymal transition","volume":"26","author":"Chen","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2147\/OTT.S291403","article-title":"Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K\/AKT\/mTOR Pathway","volume":"14","author":"Fan","year":"2021","journal-title":"OncoTargets Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.32604\/or.2024.045433","article-title":"ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K\/AKT\/mTOR signaling","volume":"32","author":"Da","year":"2024","journal-title":"Oncol. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"167794","DOI":"10.1016\/j.bbadis.2025.167794","article-title":"The CNC-family transcription factor NRF3: A crucial therapeutic target for cancer treatment","volume":"1871","author":"Yan","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Endo, M., Kamizaki, K., and Minami, Y. (2022). The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.891763"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Liu, S., Guo, J., Cheng, X., Li, W., Lyu, S., Chen, X., Li, Q., and Wang, H. (2022). Molecular Evolution of Transforming Growth Factor-\u03b2 (TGF-\u03b2) Gene Family and the Functional Characterization of Lamprey TGF-\u03b22. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.836226"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.30529","article-title":"TGF-\u03b2 signaling: A recap of SMAD-independent and SMAD-dependent pathways","volume":"237","author":"Aashaq","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Zou, M.-L., Chen, Z.-H., Teng, Y.-Y., Liu, S.-Y., Jia, Y., Zhang, K.-W., Sun, Z.-L., Wu, J.-J., Yuan, Z.-D., and Feng, Y. (2021). The Smad Dependent TGF-\u03b2 and BMP Signaling Pathway in Bone Remodeling and Therapies. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.593310"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1038\/s41598-021-94514-9","article-title":"Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-\u03b2 signaling","volume":"11","author":"Vishnubalaji","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Cecerska-Hery\u0107, E., Jerzyk, A., Goszka, M., Polikowska, A., Rachwalska, J., Serwin, N., Wojciuk, B., and Do\u0142\u0119gowska, B. (2025). TGF-\u03b2 Signaling in Cancer: Mechanisms of Progression and Therapeutic Targets. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157326"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3892\/ol.2016.4497","article-title":"Association between transforming growth factor-\u03b21 expression and the clinical features of triple negative breast cancer","volume":"11","author":"Ding","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/mmr.2015.3560","article-title":"Transforming growth factor-\u03b2, insulin-like growth factor I\/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer","volume":"12","author":"Bahhnassy","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cyto.2015.05.020","article-title":"Elevated TGF-\u03b21 and -\u03b22 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells","volume":"75","author":"Kim","year":"2015","journal-title":"Cytokine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1158\/0008-5472.CAN-18-0136","article-title":"HER2\/EGFR-AKT Signaling Switches TGF\u03b2 from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer","volume":"78","author":"Huang","year":"2018","journal-title":"Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/nar\/gkx1190","article-title":"JUNB governs a feed-forward network of TGF\u03b2 signaling that aggravates breast cancer invasion","volume":"46","author":"Sundqvist","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.18632\/aging.101983","article-title":"GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7","volume":"11","author":"Zhou","year":"2019","journal-title":"Aging"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12935-019-1068-7","article-title":"TGF-\u03b21 stimulates epithelial-mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12935-025-03973-x","article-title":"Breast neoplasm epithelial-mesenchymal transition and cytokines: A systematic review","volume":"25","author":"Chen","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"39401","DOI":"10.18632\/oncotarget.17031","article-title":"OVOL2 antagonizes TGF-\u03b2 signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_148","first-page":"1791","article-title":"Unveiling the therapeutic potential: KBU2046 halts triple-negative breast cancer cell migration by constricting TGF-\u03b21 activation in vitro","volume":"32","author":"Chen","year":"2024","journal-title":"Oncol. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1073\/pnas.0906796106","article-title":"A role for the TGFbeta-Par6 polarity pathway in breast cancer progression","volume":"106","author":"David","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.7150\/thno.71872","article-title":"RNA N6-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer","volume":"12","author":"Tan","year":"2022","journal-title":"Theranostics"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1111\/cas.15532","article-title":"ICAM1 promotes bone metastasis via integrin-mediated TGF-\u03b2\/EMT signaling in triple-negative breast cancer","volume":"113","author":"Chen","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.7150\/jca.65822","article-title":"TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-\u03b2 to Mediate EMT in Triple-Negative Breast Cancer","volume":"13","author":"Tong","year":"2022","journal-title":"J. Cancer"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2478670","DOI":"10.1080\/15384047.2025.2478670","article-title":"PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-\u03b2\/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination","volume":"26","author":"Chang","year":"2025","journal-title":"Cancer Biol. Ther."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5483\/BMBRep.2022-0180","article-title":"KPNA3 promotes epithelial-mesenchymal transition by regulating TGF-\u03b2 and AKT signaling pathways in MDA-MB-231, a triple-negative breast cancer cell line","volume":"56","author":"Choi","year":"2023","journal-title":"BMB Rep."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Yoon, S.-H., Kim, H.S., Kim, R.N., Jung, S.-Y., Hong, B.S., Kang, E.J., Lee, H.-B., Moon, H.-G., Noh, D.-Y., and Han, W. (2020). NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06840-2"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Huo, Q., Li, Z., Cheng, L., Yang, F., and Xie, N. (2020). SIRT7 is a prognostic biomarker associated with immune infiltration in luminal breast cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00621"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-018-0818-9","article-title":"miR-190 suppresses breast cancer metastasis by regulation of TGF-\u03b2-induced epithelial-mesenchymal transition","volume":"17","author":"Yu","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e2105672","DOI":"10.1002\/advs.202105672","article-title":"HTR1A inhibits the progression of triple-negative breast cancer via TGF-\u03b2 canonical and noncanonical pathways","volume":"9","author":"Liu","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5114\/biolsport.2024.129478","article-title":"Association between polymorphism rs6295 of HTR1A serotonin receptor gene and personality traits among athletes of combat sport","volume":"41","author":"Chmielowiec","year":"2024","journal-title":"Biol. Sport"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/2211-5463.13236","article-title":"Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt\/\u03b2-catenin signaling","volume":"11","author":"Xun","year":"2021","journal-title":"FEBS Open Bio"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41467-017-00396-9","article-title":"SIRT7 antagonizes TGF-\u03b2 signaling and inhibits breast cancer metastasis","volume":"8","author":"Tang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1074\/jbc.C113.544759","article-title":"A role for mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) in the regulation of hepatic gluconeogenesis","volume":"289","author":"Stark","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41420-022-01040-2","article-title":"Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"dev146589","DOI":"10.1242\/dev.146589","article-title":"Wnt signaling in development and tissue homeostasis","volume":"145","author":"Steinhart","year":"2018","journal-title":"Development"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"116685","DOI":"10.1016\/j.biopha.2024.116685","article-title":"Wnt\/\u03b2-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells","volume":"175","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14737140.2022.2016398","article-title":"The Wnt\/\u03b2-catenin pathway in breast cancer therapy: A pre-clinical perspective of its targeting for clinical translation","volume":"22","author":"Raut","year":"2022","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"101026","DOI":"10.1016\/j.gendis.2023.04.042","article-title":"The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities","volume":"11","author":"Yu","year":"2023","journal-title":"Genes Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"43124","DOI":"10.18632\/oncotarget.8988","article-title":"Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers","volume":"7","author":"De","year":"2016","journal-title":"Oncotarget"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: Advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"189440","DOI":"10.1016\/j.bbcan.2025.189440","article-title":"Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer","volume":"1880","author":"Nwokolo","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: Therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Lu\u010di\u0107, I., Kurtovi\u0107, M., Mlinari\u0107, M., Pite\u0161a, N., \u010cipak Ga\u0161parovi\u0107, A., Sabol, M., and Milkovi\u0107, L. (2023). Deciphering common traits of breast and ovarian cancer stem cells and possible therapeutic approaches. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310683"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/labinvest.2015.144","article-title":"The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: Implications in targeted cancer therapies","volume":"96","author":"Yang","year":"2016","journal-title":"Lab. Investig."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1038\/srep12465","article-title":"Blockade of Wnt\/\u03b2-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype","volume":"5","author":"Jang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"84917","DOI":"10.18632\/oncotarget.18171","article-title":"CDK3, target of miR-4469, suppresses breast cancer metastasis via inhibiting Wnt\/\u03b2-catenin pathway","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_177","first-page":"21","article-title":"RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt\/beta-Catenin Pathway","volume":"53","author":"Zhu","year":"2023","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13148-020-00959-6","article-title":"The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt\/\u03b2-catenin signaling","volume":"12","author":"Tao","year":"2020","journal-title":"Clin. Epigenet."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1111\/1759-7714.13620","article-title":"MiR-429 suppresses proliferation and invasion of breast cancer via inhibiting the Wnt\/\u03b2-catenin signaling pathway","volume":"11","author":"Zhang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_180","first-page":"111868","article-title":"AQP5 promotes epithelial-mesenchymal transition and tumor growth through activating the Wnt\/\u03b2-catenin pathway in triple-negative breast cancer","volume":"829","author":"Zhu","year":"2024","journal-title":"Mutat. Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"111331","DOI":"10.1016\/j.celrep.2022.111331","article-title":"CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression","volume":"40","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41419-020-02903-1","article-title":"DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt\/\u03b2-catenin pathway in breast cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1111\/jcmm.15520","article-title":"Ectodermal-neural cortex 1 as a novel biomarker predicts poor prognosis and induces metastasis in breast cancer by promoting Wnt\/\u03b2-catenin pathway","volume":"24","author":"Zhou","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1007\/s10528-024-10994-0","article-title":"FNDC1 facilitates proliferation, migration, and invasion of breast cancer cells through modulating Wnt\/\u03b2-catenin pathway","volume":"63","author":"Fan","year":"2025","journal-title":"Biochem. Genet."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"109361","DOI":"10.1016\/j.biopha.2019.109361","article-title":"HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt\/\u03b2-catenin signaling","volume":"118","author":"Yu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Luo, W., Zou, Y., Jiang, Y., Ma, X., Guo, S., Wang, Y., Liu, Y., Hai, L., Jia, W., and Liu, W. (2025). Keratin 6A overexpression in the lymphovascular invasion-associated tumor subgroup promotes progression of triple-negative breast cancer. Cancer Res. Treat., Epub ahead of printing.","DOI":"10.4143\/crt.2025.423"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"35728","DOI":"10.1038\/s41598-025-19599-y","article-title":"Comprehensive pan-cancer analysis of KRT6A as a prognostic and immune biomarker","volume":"15","author":"Lv","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Wang, C., Zhang, R., Wang, X., Zheng, Y., Jia, H., Li, H., Wang, J., Wang, N., Xiang, F., and Li, Y. (2021). Silencing of KIF3B suppresses breast cancer progression by regulating EMT and Wnt\/\u03b2-catenin signaling. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.597464"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-022-02373-7","article-title":"Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt\/\u03b2-catenin pathway","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Ordaz-Ramos, A., Rosales-Gallegos, V.H., Melendez-Zajgla, J., Maldonado, V., and Vazquez-Santillan, K. (2021). The role of LGR4 (GPR48) in normal and cancer processes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094690"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1096\/fj.201700897R","article-title":"LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells","volume":"32","author":"Yue","year":"2018","journal-title":"FASEB J."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.omto.2020.06.020","article-title":"LGR6 Promotes Tumor proliferation and metastasis through Wnt\/\u03b2-catenin signaling in triple-negative breast cancer","volume":"18","author":"Kong","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"AiErken, N., Wang, X., Wang, J., Ma, W., Cui, L., Zhang, M., Ma, W., and Liu, D. (2024). NUF2 promotes breast cancer metastasis via activating Wnt\/\u03b2-catenin pathways. Front. Biosci., 29.","DOI":"10.31083\/j.fbl2911371"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e70602","DOI":"10.1111\/jcmm.70602","article-title":"The Role of PAX7 in breast cancer prognosis and its mechanistic involvement in the Wnt\/\u03b2-Catenin pathway","volume":"29","author":"Ge","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12672-025-01939-z","article-title":"PGAM1: A potential therapeutic target mediating Wnt\/\u03b2-catenin signaling drives breast cancer progression","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.7150\/ijbs.68960","article-title":"PROX1 promotes breast cancer invasion and metastasis through WNT\/\u03b2-catenin pathway via interacting with hnRNPK","volume":"18","author":"Zhu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/jcmm.14219","article-title":"The latest progress on miR-374 and its functional implications in physiological and pathological processes","volume":"23","author":"Bian","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_198","first-page":"566","article-title":"MicroRNA-374a activates Wnt\/\u03b2-catenin signaling to promote breast cancer metastasis","volume":"123","author":"Cai","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41598-024-84584-w","article-title":"SLC35A2 is a novel prognostic biomarker and promotes cell proliferation and metastasis via Wnt\/\u03b2-catenin\/EMT signaling pathway in breast cancer","volume":"15","author":"Yan","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1533033820980074","DOI":"10.1177\/1533033820980074","article-title":"Effect of SALL4 on the proliferation, invasion and apoptosis of breast cancer cells","volume":"19","author":"Liu","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12935-020-01733-7","article-title":"Oncogenic UBE3C promotes breast cancer progression by activating Wnt\/\u03b2-catenin signaling","volume":"21","author":"Hang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"102241","DOI":"10.1016\/j.tranon.2024.102241","article-title":"UGCG promotes chemoresistance and breast cancer progression via NF-\u03baB and Wnt\/\u03b2-catenin pathway activation","volume":"52","author":"Long","year":"2025","journal-title":"Transl. Oncol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10799893.2020.1747490","article-title":"WHSC1 promotes wnt\/\u03b2-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Msweli, S., Pakala, S.B., and Syed, K. (2024). NF-\u03baB transcription factors: Their distribution, family expansion, structural conservation, and evolution in animals. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25189793"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"114822","DOI":"10.1016\/j.biopha.2023.114822","article-title":"The role of NF-\u03baB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy","volume":"163","author":"Pavitra","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41467-017-01829-1","article-title":"The IKK\/NF-\u03baB signaling pathway requires Morgana to drive breast cancer metastasis","volume":"8","author":"Fusella","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.31557\/APJCP.2019.20.5.1511","article-title":"The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-\u03bab), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients","volume":"20","author":"Prajoko","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/0008-5472.CAN-11-3123","article-title":"Epithelial-mesenchymal transition induced by TNF-\u03b1 requires NF-\u03baB-mediated transcriptional upregulation of Twist1","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2020.07.015","article-title":"Activation of NF-\u03baB by TOPK upregulates Snail\/Slug expression in TGF-\u03b21 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells","volume":"530","author":"Lee","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"117552","DOI":"10.1016\/j.biopha.2024.117552","article-title":"Antimigratory, effects of a new NF-\u03baB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-\u01b4-butyrolactone, in 2D and 3D breast cancer models","volume":"180","author":"Poma","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI73451","article-title":"DEAD-box helicase DP103 defines metastatic potential of human breast cancers","volume":"124","author":"Shin","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/MCB.23.1.414-423.2003","article-title":"A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity","volume":"23","author":"Yan","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7150\/ijbs.79435","article-title":"NTF4 plays a dual role in breast cancer in mammary tumorigenesis and metastatic progression","volume":"19","author":"Sun","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1038\/onc.2011.28","article-title":"Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-\u03baB: Implication in breast cancer metastasis","volume":"30","author":"Bist","year":"2011","journal-title":"Oncogene"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13058-024-01910-w","article-title":"PTPN20 promotes metastasis through activating NF-\u03baB signaling in triple-negative breast cancer","volume":"26","author":"Zuo","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"RP95318","DOI":"10.7554\/eLife.95318","article-title":"RBM7 deficiency promotes breast cancer metastasis by coordinating MFGE8 splicing switch and NF-kB pathway","volume":"13","author":"Huang","year":"2024","journal-title":"eLife"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"48889","DOI":"10.18632\/oncotarget.16522","article-title":"TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-\u03baB signaling pathways","volume":"8","author":"Lian","year":"2017","journal-title":"Oncotarget"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","article-title":"The extracellular matrix in cancer: From understanding to targeting","volume":"11","author":"Chitty","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2400370","DOI":"10.1002\/adtp.202400370","article-title":"Role of the extracellular matrix in cancer: Insights into tumor progression and therapy","volume":"8","author":"Desai","year":"2025","journal-title":"Adv. Ther."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"rbae008","DOI":"10.1093\/rb\/rbae008","article-title":"Human extracellular matrix (ECM)-like collagen and its bioactivity","volume":"11","author":"Zhou","year":"2024","journal-title":"Regen. Biomater."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"100515","DOI":"10.1016\/j.xcrp.2021.100515","article-title":"The mechanics of fibrillar collagen extracellular matrix","volume":"2","author":"Sun","year":"2021","journal-title":"Cell Rep. Phys. Sci."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ceb.2010.08.015","article-title":"Dynamic interplay between the collagen scaffold and tumor evolution","volume":"22","author":"Egeblad","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biomaterials.2016.08.052","article-title":"Heralding a new paradigm in 3D tumor modeling","volume":"108","author":"Fong","year":"2016","journal-title":"Biomaterials"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Dinkel, Z., Baker, A., Akins, A., King, K.L., Harrington, M., Kunkel, D., Gao, Z., Ye, T., and Dunn, H. (2025). Collagen architecture in triple negative breast cancer. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0324655"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.18632\/oncotarget.13716","article-title":"siRNA-mediated suppression of collagen type IV alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/OTT.S256818","article-title":"A six-epithelial-mesenchymal transition gene signature may predict metastasis of triple-negative breast cancer","volume":"13","author":"Wei","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/mc.23747","article-title":"Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt\/\u03b2-catenin signaling","volume":"63","author":"Peng","year":"2024","journal-title":"Mol. Carcinog."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13058-018-1030-y","article-title":"Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance","volume":"20","author":"Zhang","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"e37906","DOI":"10.1002\/jbm.a.37906","article-title":"Extracellular fibronectin and hyaluronic acid effects on tumorigenic functions of triple-negative breast cancer cells","volume":"113","author":"Heiss","year":"2025","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Du, W., Xia, X., Hu, F., and Yu, J. (2024). Extracellular matrix remodeling in the tumor immunity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1340634"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"118781","DOI":"10.1016\/j.bbamcr.2020.118781","article-title":"Leading the invasion: The role of Cathepsin S in the tumour microenvironment","volume":"1867","author":"McDowell","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Cheng, T., Chen, P., Chen, J., Deng, Y., and Huang, C. (2022). Landscape analysis of matrix metalloproteinases unveils key prognostic markers for patients with breast cancer. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.809600"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cytogfr.2021.10.006","article-title":"Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer","volume":"62","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Kwon, M.J. (2023). Matrix metalloproteinases as therapeutic targets in breast cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1108695"},{"key":"ref_239","first-page":"1732","article-title":"MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors in vitro","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Kmiecik, A.M., Pula, B., Suchanski, J., Olbromski, M., Gomulkiewicz, A., Owczarek, T., Kruczak, A., Ambicka, A., Rys, J., and Ugorski, M. (2015). Metallothionein-3 increases triple-negative breast cancer cell invasiveness via induction of metalloproteinase expression. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124865"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Dey, N., Young, B., Abramovitz, M., Bouzyk, M., Barwick, B., De, P., and Leyland-Jones, B. (2013). Differential activation of Wnt-\u03b2-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077425"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-020-05670-x","article-title":"Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival","volume":"182","author":"Joseph","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/s40064-015-1512-7","article-title":"High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature","volume":"4","author":"Asztalos","year":"2015","journal-title":"Springerplus"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41598-025-87286-z","article-title":"Mechanistic insights into pachymic acid\u2019s action on triple-negative breast cancer through TOP2A targeting","volume":"15","author":"Liu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.1038\/s41598-025-05538-4","article-title":"MMP14 and DDR2 are potential molecular markers for metastatic triple-negative breast cancer","volume":"15","author":"Ahmad","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"e2104162118","DOI":"10.1073\/pnas.2104162118","article-title":"Drivers and suppressors of triple-negative breast cancer","volume":"118","author":"Wu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-022-06514-6","article-title":"Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT","volume":"193","author":"Zhu","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Jiang, H., and Li, H. (2021). Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: A systematic review and meta-analysis. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07860-2"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cas.12309","article-title":"Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2","volume":"105","author":"Ni","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.3892\/or.2017.5588","article-title":"Silibinin downregulates MMP2 expression via Jak2\/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells","volume":"37","author":"Byun","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_251","first-page":"6543230","article-title":"Brucine suppresses vasculogenic mimicry in human triple-negative breast cancer celllLine MDA-MB-231","volume":"2019","author":"Xu","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.18632\/oncotarget.1932","article-title":"Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer","volume":"5","author":"Mehner","year":"2014","journal-title":"Oncotarget"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"153437","DOI":"10.1016\/j.phymed.2020.153437","article-title":"Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT\/mTOR signaling pathway","volume":"81","author":"Wu","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10549-014-2989-4","article-title":"Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors","volume":"146","author":"Sizemore","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"24631","DOI":"10.1074\/jbc.M112.375865","article-title":"The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression","volume":"287","author":"Sizemore","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jat.2941","article-title":"Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K\/Akt signaling pathway","volume":"34","author":"Yang","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"ref_257","first-page":"2801","article-title":"The anticancer effect of 2\u2032-3\u2032-dehydrosalannol on triple-negative breast cancer cells","volume":"32","author":"Boopalan","year":"2012","journal-title":"Anticancer. Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2018.05.148","article-title":"Cathepsins: Proteases that are vital for survival but can also be fatal","volume":"105","author":"Patel","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_259","first-page":"29","article-title":"Cathepsin L is a potential marker for triple-negative breast cancer","volume":"11","author":"Hassan","year":"2019","journal-title":"Egypt. Acad. J. Biol. Sci. C Physiol. Mol. Biol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/osteology1010002","article-title":"The role of cathepsins in the growth of primary and secondary neoplasia in the bone","volume":"1","author":"Fasanya","year":"2020","journal-title":"Osteology"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"e007135","DOI":"10.1136\/jitc-2023-007135","article-title":"A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer","volume":"12","author":"Lajoie","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canlet.2018.09.021","article-title":"Cathepsin D enhances breast cancer invasion and metastasis through promoting hepsin ubiquitin-proteasome degradation","volume":"438","author":"Zhang","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-11-2759","article-title":"Cathepsin B inhibition limits bone metastasis in breast cancer","volume":"72","author":"Withana","year":"2012","journal-title":"Cancer Res."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Kelley, C., Guarin, J.R., Henrich, E., Fatherree, J.P., Dunn, C.M., Yui, A., and Oudin, M.J. (2025). Cell-line specific role of Cathepsin B in triple-negative breast cancer growth, invasion and response to chemotherapy. bioRxiv.","DOI":"10.1101\/2025.11.04.686610"},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Gao, H., Zhang, Z., Deng, J., and Song, Y. (2025). Cathepsin S: Molecular mechanisms in inflammatory and immunological processes. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1600206"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.febslet.2004.12.093","article-title":"Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans","volume":"579","author":"Vasiljeva","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12931-020-01381-5","article-title":"Cathepsin S: Investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics","volume":"21","author":"Brown","year":"2020","journal-title":"Respir. Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ncb3011","article-title":"Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S","volume":"16","author":"Sevenich","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0135-9","article-title":"Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis","volume":"50","author":"Gautam","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","article-title":"Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer","volume":"11","author":"Saatci","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-013-2662-3","article-title":"LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients","volume":"141","author":"Ahn","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.18632\/oncotarget.14450","article-title":"LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer","volume":"8","author":"Choi","year":"2017","journal-title":"Oncotarget"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/9\/809\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:15:17Z","timestamp":1777608917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/9\/809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":273,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cells15090809"],"URL":"https:\/\/doi.org\/10.3390\/cells15090809","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}